Literature DB >> 22828750

Central vasopressin V1A receptor blockade impedes hypothalamic-pituitary-adrenal habituation to repeated restraint stress exposure in adult male rats.

Megan Gray1, Leyla Innala, Victor Viau.   

Abstract

Previous studies suggest that central arginine vasopressin (AVP) signaling can inhibit the hypothalamic-pituitary-adrenal (HPA) axis. To test a role for the AVP V1A receptor in stress HPA axis habituation, adult male rats were exposed to 5 consecutive days of 3 h restraint with or without continuous intracerebroventricular infusion of the V1A receptor antagonist d(CH2)5Tyr(Me)AVP (10 μg/day). Assessment of neuropeptide expression and HPA output under basal conditions revealed no effects of V1A receptor antagonism in stress naive animals. Between the first and last day of restraint exposure, controls showed marked declines in ACTH and corticosterone responses, and maintained plasma concentrations of testosterone. In contrast, V1A receptor antagonized animals displayed significantly smaller declines in ACTH and corticosterone responses, and a decrease in plasma testosterone. Despite their reduced expression of HPA axis habituation, antagonized animals continued to show stress-induced increases in AVP mRNA in the hypothalamic paraventricular nucleus and bed nucleus of the stria terminalis, and even higher levels of AVP expression in the medial amygdala relative to controls. The data leave open the nature and extent to which these and other AVP-containing pathways are recruited during repeated restraint, but nevertheless reveal a critical role for central V1A receptors in stress adaptation. As the effects of V1A receptor antagonism were restricted to the repeated restraint condition, we conclude that normal adaptation to stress involves a shift toward enhanced AVP utilization and/or V1A receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828750      PMCID: PMC3473337          DOI: 10.1038/npp.2012.136

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  39 in total

Review 1.  Role of vasopressin in learning and memory in the hippocampus.

Authors:  B Alescio-Lautier; B Soumireu-Mourat
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

Review 2.  Stress and the brain: from adaptation to disease.

Authors:  E Ron de Kloet; Marian Joëls; Florian Holsboer
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

Review 3.  Central organization of androgen-sensitive pathways to the hypothalamic-pituitary-adrenal axis: implications for individual differences in responses to homeostatic threat and predisposition to disease.

Authors:  Martin Williamson; Brenda Bingham; Victor Viau
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-10-07       Impact factor: 5.067

4.  Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors.

Authors:  P Poulin; P Szot; D M Dorsa; Q J Pittman
Journal:  Eur J Pharmacol       Date:  1995-12-27       Impact factor: 4.432

Review 5.  The central vasopressinergic system: examining the opportunities for psychiatric drug development.

Authors:  Robert H Ring
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 6.  Effects of vasopressin and related peptides on neurons of the rat lateral septum and ventral hippocampus.

Authors:  I J Urban
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

Review 7.  Neural circuitry in the regulation of adrenal corticosterone rhythmicity.

Authors:  William C Engeland; Michelle M Arnhold
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

8.  Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain.

Authors:  C Vaccari; S J Lolait; N L Ostrowski
Journal:  Endocrinology       Date:  1998-12       Impact factor: 4.736

9.  Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons.

Authors:  C T Wotjak; J Ganster; G Kohl; F Holsboer; R Landgraf; M Engelmann
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

10.  Glucocorticoid regulation of vasopressin V1a receptors in rat forebrain.

Authors:  J J Watters; C W Wilkinson; D M Dorsa
Journal:  Brain Res Mol Brain Res       Date:  1996-06
View more
  9 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

2.  Chronic Variable Stress Induces Sex-Specific Alterations in Social Behavior and Neuropeptide Expression in the Mouse.

Authors:  Amanda P Borrow; Natalie J Bales; Sally A Stover; Robert J Handa
Journal:  Endocrinology       Date:  2018-07-01       Impact factor: 4.736

3.  Anxiety-like behavior and neuropeptide receptor expression in male and female prairie voles: The effects of stress and social buffering.

Authors:  Meghan Donovan; Yan Liu; Zuoxin Wang
Journal:  Behav Brain Res       Date:  2018-01-31       Impact factor: 3.332

Review 4.  Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development?

Authors:  Nikolaos Kokras; Georgia E Hodes; Debra A Bangasser; Christina Dalla
Journal:  Br J Pharmacol       Date:  2019-06-26       Impact factor: 8.739

5.  Chronic Postnatal Stress Induces Depressive-like Behavior in Male Mice and Programs second-Hit Stress-Induced Gene Expression Patterns of OxtR and AvpR1a in Adulthood.

Authors:  Alexandra Lesse; Kathy Rether; Nicole Gröger; Katharina Braun; Jörg Bock
Journal:  Mol Neurobiol       Date:  2016-08-15       Impact factor: 5.590

6.  Inhibition of vasopressin V1a receptors in the medioventral bed nucleus of the stria terminalis has sex- and context-specific anxiogenic effects.

Authors:  Natalia Duque-Wilckens; Michael Q Steinman; Sarah A Laredo; Rebecca Hao; Allison M Perkeybile; Karen L Bales; Brian C Trainor
Journal:  Neuropharmacology       Date:  2016-07-21       Impact factor: 5.250

7.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

8.  The Pituitary-Adrenal Response to Paradoxical Sleep Deprivation Is Similar to a Psychological Stressor, Whereas the Hypothalamic Response Is Unique.

Authors:  Danilo A Moraes; Ricardo B Machado; Michael Koban; Gloria E Hoffman; Deborah Suchecki
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-08       Impact factor: 6.055

Review 9.  Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.

Authors:  Nina Japundžić-Žigon; Maja Lozić; Olivera Šarenac; David Murphy
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.